Julie A. Vetalice, Author at ORTHOWORLD

Preclinical Study Validates Science Behind AlloSource AlloStem Cellular Bone Allograft

Preclinical data on adipose-derived mesenchymal stem cells in a rat model, using technology similar to AlloSource’s AlloStem® Cellular Bone Allograft process, showed bone formation within a critical-sized defect in all study subjects.

Jul 06, 2016

Merit Medical Acquires DFINE

Competitive Landscape Mergers & Acquisitions

Merit Medical Systems, manufacturer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, acquired DFINE in a merger transaction for ~US $97.5MM in cash.

Jul 06, 2016

First Implantation of Camber Spine’s Enza Zero-Profile ALIF Device

ORTHOFLASH Spine

Camber Spine Technologies announced the first implantation of the ENZA™ MIS Zero-Profile ALIF device, occuring in a 2-level lumbar procedure.

Jul 06, 2016

Two-year Clinical Results for Spineart’s Baguera C Cervical Disc

ORTHOFLASH Spine

Study results indicate that patients treated with Spineart’s BAGUERA® C cervical disc in 1- or 2-level arthroplasty exhibited good mobility at treated and adjacent levels, disc height restoration and evidence of adjacent level preservation.

Jul 06, 2016

Bioventus Extends Distribution Agreement for SUPARTZ FX Viscosupplement

Company Updates Competitive Landscape

Bioventus entered into an agreement with Seikagaku to continue U.S. distribution of SUPARTZ FX™ viscosupplement through May 2019.

Jul 05, 2016

NuVasive Completes Acquistion of Biotronic NeuroNetwork

Competitive Landscape Mergers & Acquisitions

NuVasive completed its previously-announced acquisition of Biotronic NeuroNetwork, which is now part of the NuVasive Clinical Services division.

Jul 05, 2016

Amedica Prices $11 Million Public Offering

Investments The Numbers

Amedica priced an underwritten public offering for gross proceeds of US $11MM, prior to various deductions. Closing is expected to occur by 7/8/16.

Jul 05, 2016

Cartiva Announces FDA Premarket Approval for Cartiva Synthetic Cartilage Implant

Orthobiologics ORTHOFLASH

Cartiva received FDA Premarket Approval for the Synthetic Cartilage Implant to treat arthritis of the great toe. Product introduction will occur within 7/16.

Jul 05, 2016

Bioventus Files for $150MM IPO

Investments The Numbers

Bioventus registered for an initial public offering at a placeholder amount of $150MM.

Jul 01, 2016

Prosidyan Announces Joint Collaboration, License Agreement with MO-SCI

Company Updates Competitive Landscape

Prosidyan entered into a joint collaboration and license agreement with MO-SCI Corporation for a technology using boron-based bioactive glass materials for applications in spine and trauma.

Jul 01, 2016

Get the ORTHOWORLD Newsletter!

Contact Us